New Cancer Treatments

Yesterday, the Federal Drug Administration (FDA) granted Roche subsidiary Genentech’s pertuzumab regular approval for treatment for HER2-Positive early breast cancer patients at high risk of recurrence. […]

President Jimmy Carter gained national attention when he announced that his doctors could no longer find any proof of melanoma in his body. That exciting news was due in large part to a ground-breaking type […]